Literature DB >> 10081969

Molecular cloning of human Fe65L2 and its interaction with the Alzheimer's beta-amyloid precursor protein.

H Tanahashi1, T Tabira.   

Abstract

We report the cDNA sequence of human Fe65L2. The human Fe65L2 encoded 486 amino acids; the deduced amino acid sequence was shorter by 18 amino acids than the rat protein and had 86% identity to the rat protein Three protein-protein interaction domains, a WW and two PID/PTB elements, were conserved among the Fe65 protein family. Human Fe65L2 mRNA was expressed in various tissues; a transcript of about 2.2 kb was mainly expressed in the brain. A splicing variant lacking two amino acids in the first PID/PTB element was detected. We also confirmed that the carboxyl-terminal region of PID/PTB of the Fe65L2 interacted with the intracellular domain of the Alzheimer's beta-amyloid precursor protein (APP) and APP-like proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081969     DOI: 10.1016/s0304-3940(98)00995-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

Authors:  Scott A Small; Sam Gandy
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

2.  The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement.

Authors:  S L Sabo; A F Ikin; J D Buxbaum; P Greengard
Journal:  J Cell Biol       Date:  2001-06-25       Impact factor: 10.539

3.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

4.  Characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms lacking phosphotyrosine-interaction domains.

Authors:  Hiroshi Tanahashi; Takeshi Tabira
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

5.  Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.

Authors:  Edoardo Marcora; Alison M Goate; Gloriia Novikova; Manav Kapoor; Julia Tcw; Edsel M Abud; Anastasia G Efthymiou; Steven X Chen; Haoxiang Cheng; John F Fullard; Jaroslav Bendl; Yiyuan Liu; Panos Roussos; Johan Lm Björkegren; Yunlong Liu; Wayne W Poon; Ke Hao
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

6.  C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65.

Authors:  Madepalli K Lakshmana; Eunice Chen; Il-Sang Yoon; David E Kang
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

Review 7.  Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics.

Authors:  Anna Podleśny-Drabiniok; Edoardo Marcora; Alison M Goate
Journal:  Trends Neurosci       Date:  2020-10-27       Impact factor: 16.978

8.  Alzheimer's disease and HIV associated dementia related genes: I. location and function.

Authors:  Paul Shapshak; Hector E Rodriguez; Rajarathinam Kayathri; Andrew Levine; Francesco Chiappelli; Alireza Minagar
Journal:  Bioinformation       Date:  2008-05-29

Review 9.  Fe65: A Scaffolding Protein of Actin Regulators.

Authors:  Vanessa Augustin; Stefan Kins
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

10.  Accurate spliced alignment of long RNA sequencing reads.

Authors:  Kristoffer Sahlin; Veli Mäkinen
Journal:  Bioinformatics       Date:  2021-07-24       Impact factor: 6.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.